Neuropad in the news

In 2016 neuropad was submitted for consideration by the NHS Innovation Accelerator programme and was shortlisted by a panel of assessors which included NHS national clinical directors, Academic Health Science Network representatives, charities, patient representatives as well as commercial experts drawn from the public and private sectors. It was shortlisted on the basis that neuropad® is ‘a good, patient-centred innovation that has the potential to improve screening for foot problems in people with diabetes and therefore reduce preventable foot ulceration and amputation, which are expensive for the NHS and devastating...

A new study presented at the specialist Diabetic Foot Study Group (DFSG) of the European Association for the Study of Diabetes (EASD) in Stuttgart, Germany, in September 2016 provides further evidence of the high sensitivity that neuropad® has for the prediction of future foot ulceration in people with diabetes. The prospective study conducted by lead investigator Dr Irene Sanz Corbalán and colleagues enrolled 263 patients consecutively from the Diabetic Foot Unit of the Complutense University of Madrid between July 2011 and April 2015. Diabetic patients without an active foot ulcer were...

If you have diabetes, taking good care of your feet can prevent complications from developing. Here are a few simple tips that you can take to reduce your risk. The most important action you can take is to keep your blood sugar within acceptable levels and, if you have Type 2 diabetes treated with tablets, to take your medication as prescribed and not to skip a dose no matter how well you might feel at the time. If you have Type 1 diabetes and regularly inject insulin, or if you have...

According to the results of Diabetes UK’s 2015 care survey, only 69% of people with Type 1 diabetes stated that they are having their legs and feet checked, compared with 80% of people with Type 2. This may be because people with Type 2 are more likely to have their feet checked by their GP, who, through QoF (Quality Outcomes Framework) are financially incentivised to deliver this service. Worryingly, those who had their feet checked were often not asked to remove their socks or tights nor even had the soles of...

A simple, non-invasive 10-minute screening test called neuropad® that may help address the worryingly and stubbornly high incidence of foot ulcers and amputations is now available in the UK having been available for some time in Germany, Switzerland and Austria. Diabetes patients will now be able to check for nerve damage using a very simple home device which works by detecting sweat. It’s like an early-warning system for your feet. The new stick-on pad changes colour from blue to pink when all is well, but remains blue or partially changes to pink,...